Drug intelligence / Profile preview

Qlarity

Development stage
Unknown
Lead developer
Quantum BioPharma
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
01

Overview

Qlarity is a natural health product (NHP) developed by Dr. Lakshmi P. Kotra's research group at the University of Toronto and the University Health Network (UHN). Authorized by Health Canada under Natural Product Number (NPN) 80144141, the product is a standardized botanical extract derived from green coffee beans (*Coffea canephora*). It is specifically formulated to contain a defined ratio of caffeine and chlorogenic acids (primarily 5-O-caffeoylquinic acid). Qlarity is marketed to support metabolic health and enhance mental alertness by leveraging the synergistic effects of its primary phytochemical constituents. The formulation aims to provide cognitive and metabolic benefits while minimizing the jitteriness often associated with high-dose caffeine consumption.

Brand names
Qlarity
Other names
Qlarity
02

Targets

G6PC1 (Glucose 6-phosphatase alpha)ADOR (Adenosine receptors)Sucrase-Isomaltase

Beyond the preview

Go deeper on Qlarity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qlarity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call